Cleared Traditional

K223263 - Prevena Plus 125 Therapy Unit

K223263 is an FDA 510(k) clearance for Prevena Plus 125 Therapy Unit, manufactured by 3M. The device is a Class 2 General & Plastic Surgery device with product code QFC cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K223263 · 3M · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
112d
Days
Class 2
Risk

K223263 is an FDA 510(k) clearance for the Prevena Plus 125 Therapy Unit. Classified as Negative Pressure Wound Therapy Device For Reduction Of Wound Complications (product code QFC), Class II - Special Controls.

Submitted by 3M (San Antionio, US). The FDA issued a Cleared decision on February 13, 2023 after a review of 112 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4783 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all 3M devices

FDA 510(k) Submission Details - K223263

510(k) Number K223263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 2022
Decision Date February 13, 2023
Days to Decision 112 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 115d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

QFC Device Classification - Class 2, Special Controls

Product Code QFC Negative Pressure Wound Therapy Device For Reduction Of Wound Complications
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4783
Definition A Negative Pressure Wound Therapy Device For Reduction Of Wound Complications Is A Powered Suction Pump Intended For Wound Management And Reduction Of Wound Complications Via Application Of Negative Pressure To The Wound, Which Removes Fluids, Including Wound Exudate, Irrigation Fluids, And Infectious Materials. This Device Type Is Intended For Use With Wound Dressings Classified Under 21 Cfr 878.4780. This Classification Does Not Include Devices Intended For Organ Space Wounds.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - QFC Negative Pressure Wound Therapy Device For Reduction Of Wound Complications

Devices cleared under the same product code (QFC) and FDA review panel - the closest regulatory comparables to K223263.
PICO Single Use Negative Pressure Wound Therapy System, PICO 7 Single Use Negative Pressure Wound Therapy System, PICO 7Y Single Use Negative Pressure Wound Therapy System, PICO 14 Single Use Negative Pressure Wound Therapy System
K203716 · Smith and Nephew Medical Limited · Dec 2021
PREVENA 125 and PREVENA PLUS 125 Therapy Units
DEN180013 · Kci USA, Inc. · Apr 2019